Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
134 participants
INTERVENTIONAL
2008-02-29
2009-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The cause of this difference can be due to some factors such as the endometrial receptivity, quality of transferred embryos and embryo transfer technique. Retained or expelled embryo(s) following embryo transfer is (are) one of the factors which may be effective on outcome. The purpose of this randomized clinical trial study is "Lowering embryo expulsion following embryo transfer to improve outcome."
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of 5 Day Embryo Transfer With 2-3 Day Transfer in Patients With Previous In Vitro Fertilization Failure
NCT01107002
Does Transfer of Poor-quality Embryos With Good-quality Embryos Improve Pregnancy Outcome in Women Undergoing IVF/ICSI?
NCT03113097
The Clinical Outcomes Following Transfer of Blastocysts Cultured From Thawed Cleavage Stage Embryos
NCT02681029
Effect of Cervical Discharge Removal During ET on Pregnancy Rate
NCT01156181
Autologous Mitochondrial Transfer in ICSI to Improve Oocyte and Embryo Quality in IVF Patients. Pilot Study
NCT02586298
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
After the ovarian stimulation and oocyte retrieval, The IVF and intracytoplasmic sperm injection (ICSI) procedures will be performed to produce the embryos.
Embryo transfer will be done only by one skilled physician. The patients will be divided into two groups of A and B by computerized randomly chart. In group A, the prevention technique of embryo expulsion will be carried out following embryo transfer, but no intervention will be performed in group B (control group).
After 2 weeks, the patients will be tested for serum β-hCG for assessing the pregnancy. The clinical pregnancy will be clarified by the number of women with gestational sacs on transvaginal sonography at 4-6 weeks of gestation. In the calculation of implantation, the number of gestational sacs will be considered.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Group
Embryo transfer without any intervention
No interventions assigned to this group
Embryo Expulsion
prevention of embryo expulsion
The prevention of embryo expulsion will be carried out after embryo transfer
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
prevention of embryo expulsion
The prevention of embryo expulsion will be carried out after embryo transfer
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with "long or antagonist" protocol
Exclusion Criteria
* Those with oocyte donation cycle
* The women with uterine abnormality
* The women with submucosal and intramural myoma
* Who does not have good-quality embryos appropriate
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royan Institute
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Royan Institute
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Tahere Madani, MD
Role: PRINCIPAL_INVESTIGATOR
Royan Institute
Mahnaz Ashrafi, MD
Role: PRINCIPAL_INVESTIGATOR
Royan Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royan Institute
Tehran, Tehran Province, Iran
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Official site
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Royan-Emb-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.